EUCTR2017-000988-32-IT进行中(未招募)1 期
A Comparative, Open-Label, Randomized, Parallel Group Study to determine Intraperitoneal fluids, tissue, and serum concentrations of VML-0501 following five days of daily vaginal applications of single dose of VML-0501 (100 mg Danazol), in comparison to five days of Danazol treatment administered as an oral capsules (Danatrol) at a daily dose of 600 mg, in two groups of twelve each consisting of women with suspected or confirmed endometriosis and scheduled for laparoscopy. - VML-0501-001
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •The subject must:
- •Provide written (personally signed and dated) informed consent before completing any study-related procedure, which means any assessment or evaluation that would not have formed a part of her normal medical care.
- •Be a female with signs and symptoms of endometriosis
- •Greater than or equal to 18 years of age and less than 42years.
- •Scheduled to undergo laparoscopy.
- •According to the local practice the women should sign a specific clause on avoiding pregnancy based on the use of two effective methods for birth control (condom and spermicidal) following 30 days after the last dose/application.
- •Be non-pregnant undergoing laparoscopy with signs and symptoms of endometriosis within first 10 days of her cycle.
- •Have a body mass index (BMI) < 32 kg/m2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 24
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •If any of the following criteria apply, the subject MUST NOT be admitted/continue the study trial.
- •The subject:
- •Is pregnant (if positive-Urine pregnancy test at screening) or lactating;
- •Has evidence of drug or alcohol abuse.
- •Have used hormonal replacement therapy or Danazol therapy within the past 8 weeks before study entry
- •Has any of the following: Epileptic Seizure, Migraine Headache, Angina, Chronic Heart Failure, Obstruction of a Blood Vessel by a Blood Clot, Liver Problems, Kidney Disease, Pregnancy, Combined High Blood Cholesterol and Triglyceride Level, Porphyria
- •Undiagnosed abnormal genital bleeding
- •Androgen dependant tumour
- •Is Allergic to anabolic androgenic steroid.
研究者
相似试验
尚未招募
3 期
A clinical trial to study the efficacy and safety of Budesonide Dry Powder Inhaler Rotacaps in Patients with Mild to Moderate Asthma.CTRI/2011/06/001788Inventia Healthcare Private Limited20
已完成
4 期
A study to evaluate the efficacy and safety of 3 study drugs in treatment of patients with with any type of eczematous disorderassociated with underlying tinea / yeast infectioCTRI/2012/09/003000Abbott Healthcare Pvt Ltd54
已完成
2 期
A clinical evaluation of AHPL/AYTOP/0113 cream in comparison with Framycetin Sulphate cream in patients of acute woundsCTRI/2014/01/004304Ari Healthcare Pvt Ltd R D Centre80
已完成
4 期
Study to examine the body response of Peg-filgrastim against Neulasta® along with Chemical agent in Patients with Breast Cancer who will be selected in any order to a known treatment.CTRI/2018/02/011914upin Limited Biotechnology Division138
已完成
3 期
A Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Lubiprostone Soft Gelatin capsules 24 mcg Vs Bisacodyl tablet 10 mg in the patients with chronic constipation.CTRI/2010/091/000586Ajanta Pharma Ltd200
